文献速递临床试验与 GCP真实世界研究与卫生经济

急诊科物理治疗师主导肌肉骨骼疾病照护的随机对照试验及经济学评价

Physiotherapist-led care for musculoskeletal conditions in the emergency department (RESHAP-ED): a randomised controlled trial with economic evaluation.
PubMed 文献 · Lancet · 2026-08-27

RESHAP-ED 为在澳大利亚五家急诊科开展的开放标签实用随机试验,纳入 1491 例无并发症肌肉骨骼疾病成人,比较物理治疗师主导照护与常规医生/执业护士主导照护。

核心结论

  • 物理治疗师主导的急诊照护模式可缩短无并发症肌肉骨骼疾病患者的急诊停留时间,不损害健康结局或安全性,且具有成本效果。

研究设计与样本

  • RESHAP-ED 为开放标签、实用随机对照试验,在澳大利亚新南威尔士州五家急诊科招募 18 岁及以上无并发症肌肉骨骼疾病成人。
  • 参与者按 1:1 随机分配至物理治疗师主导照护组或常规医生/执业护士主导照护组,采用统计师生成的随机置换区组。
  • 共筛查 4219 例,2728 例不符合纳入标准,1491 例随机分配(干预组 746 例,对照组 745 例);随机后排除 16 例,最终分析 1475 例(干预组 737 例,对照组 738 例)。
  • 主要结局为急诊停留时间(从到达到离院),在意向性治疗人群中采用线性混合效应模型分析,主要结局随访完成率 100%。

临床怎么用

  • 对于急诊科就诊的无并发症肌肉骨骼疾病成人,可考虑采用物理治疗师主导的照护模式以缩短急诊停留时间并降低医疗成本。
  • 该模式在安全性方面与常规照护相当,不良事件发生率无显著差异。

局限性

  • 试验为开放标签设计,参与者与实施者知晓分组,可能引入偏倚。
  • 研究仅在澳大利亚新南威尔士州五家急诊科开展,外推至其他医疗体系需谨慎。
  • 纳入人群为无并发症肌肉骨骼疾病成人,不适用于需骨科会诊或手术的复杂病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long stays in the emergency department compromise patient safety and health system performance. Physiotherapist-led models of care may improve care and emergency department performance, but their effects have not been rigorously evaluated in randomised trials. We compared the effectiveness, safety, and cost-effectiveness of physiotherapist-led care with usual care for patients presenting to the emergency department with musculoskeletal conditions. METHODS: RESHAP-ED was an open-label, pragmatic, randomised trial that recruited adults aged 18 years and older at five emergency departments in New South Wales, Australia, with uncomplicated musculoskeletal conditions (eg, soft tissue conditions, neck and back pain, and fractures or dislocations not requiring orthopaedic review or surgery). Participants were randomly assigned (1:1), using statistician-generated randomly permuted blocks, to either physiotherapist-led care (intervention) or usual physician-led or nurse practitioner-led care (control). The primary outcome was length of stay in the emergency department, calculated as time from arrival to discharge, analysed in the intention-to-treat population using a linear mixed-effects model. The trial was prospectively registered on the Australian New Zealand Clinical Trials Registry (ACTRN12623000782639) and is completed. FINDINGS: Between Nov 22, 2023 and March 29, 2025, 4219 patients were screened, 2728 were deemed ineligible for inclusion, and 1491 participants were randomly assigned (746 assigned to the physiotherapy-led intervention group and 745 assigned to the physician-led or nurse-led practitioner control group). Following the exclusion of 16 participants after randomisation, 1475 were included in the analysis (737 in the intervention group and 738 in the control group). The mean age of participants was 40·1 years (SD 16·5). 719 (48·7%) participants were male, 755 (51·2%) were female, and one (0·1%) participant had unreported sex data. Follow-up for the primary outcome was 100% complete. The mean length of stay in the emergency department was 2·4 h in the intervention group and 3·4 h in the control group (-1·0 h [95% CI -1·2 to -0·8]). Adverse events were reported by 39 (6·6%) of 591 participants in the intervention group versus 33 (5·9%) of 555 in the control group (p=0·72). The intervention group had lower costs (-$35·1 [95% CI -69·0 to -1·7]) and a high probability (98·1%) of being cost-effective. INTERPRETATION: A physiotherapist-led model of care in the emergency department reduced length of stay among patients presenting with uncomplicated musculoskeletal conditions, without compromising health outcomes or safety, and was cost-effective. FUNDING: Medical Research Future Fund.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Sigera C, Campos TF, Coombs DM, et al. Physiotherapist-led care for musculoskeletal conditions in the emergency department (RESHAP-ED): a randomised controlled trial with economic evaluation. Lancet. 2026. PMID: 42660158. doi:10.1016/S0140-6736(26)01327-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。